Xtant Medical Holdings (XTNT) Total Debt Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Xtant Medical Holdings | 64.46 Mn | 47.14 Mn | 17.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.43% |
| Sep 30, 2025 | -18.45% |
| Jun 30, 2025 | -15.06% |
| Mar 31, 2025 | -15.45% |
| Dec 31, 2024 | -14.84% |
| Sep 30, 2024 | -15.65% |
| Jun 30, 2024 | -14.54% |
| Mar 31, 2024 | -17.91% |
| Dec 31, 2023 | -22.50% |
| Sep 30, 2023 | -24.74% |
| Jun 30, 2023 | -26.46% |
| Mar 31, 2023 | 206.50% |
| Dec 31, 2022 | -27.94% |
| Sep 30, 2022 | 124.96% |
| Jun 30, 2022 | 144.94% |
| Mar 31, 2022 | 148.34% |
| Dec 31, 2021 | 115.23% |
| Sep 30, 2021 | -21.17% |
| Jun 30, 2021 | -21.28% |
| Mar 31, 2021 | -19.26% |
| Dec 31, 2020 | -17.61% |
| Sep 30, 2020 | 11.92% |
| Jun 30, 2020 | 28.95% |
| Mar 31, 2020 | 27.38% |
| Dec 31, 2019 | 29.52% |
| Jun 30, 2019 | 29.73% |
| Mar 31, 2019 | 26.19% |
| Dec 31, 2018 | 35.55% |
| Sep 30, 2018 | 35.53% |
| Jun 30, 2018 | 36.60% |
| Mar 31, 2018 | -66.56% |
| Dec 31, 2017 | 34.17% |
| Sep 30, 2017 | -58.06% |
| Jun 30, 2017 | -51.96% |
| Mar 31, 2017 | -54.39% |
| Dec 31, 2016 | -48.24% |
| Sep 30, 2016 | 43.29% |
| Jun 30, 2016 | 55.28% |
| Dec 31, 2015 | 74.13% |